Stay updated on CSJ117 Efficacy in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the CSJ117 Efficacy in Severe Asthma Clinical Trial page.

Latest updates to the CSJ117 Efficacy in Severe Asthma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedLocation groupings were expanded to include US states (California, Colorado, Georgia, Maine, Maryland, Massachusetts, Missouri, Nebraska, North Carolina, Oklahoma, Pennsylvania, South Carolina, Texas) and international sites (Buenos Aires, Entre Ríos Province, Rosario, Santa Fe Province, Tucumán Province, Ontario, Quebec, CZE, Lower Saxony, GTM, Kanagawa, Osaka, Tokyo, LV). The page also shows Revision: v3.3.3.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page no longer displays the government funding/operating status notice that previously appeared on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check69 days agoChange DetectedThe new screenshot shows styling/layout adjustments only; all substantive sections appear unchanged, including study design, arms, outcomes, and locations. No new results or status updates are present.SummaryDifference0.2%

- Check92 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check99 days agoChange DetectedAdded version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several core safety sections. If these deletions are intended, this is a major reduction in detailed drug-safety content.SummaryDifference0.2%

Stay in the know with updates to CSJ117 Efficacy in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CSJ117 Efficacy in Severe Asthma Clinical Trial page.